| 1 |
Vandewoude KH, Blot SI, Benoit D, et al. Invasive aspergillosis in critically ill patients: attributable mortality and excesses in length of ICU stay and ventilator dependence[J]. J Hosp Infect, 2004, 56 (4): 269-276.
|
| 2 |
Walsh TJ, Pappas P, Winston DJ, et al. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever[J]. N Engl J Med, 2002, 346 (4): 225-234.
|
| 3 |
Walsh TJ, Teppler H, Donowitz GR, et al. Caspofung-in versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia[J]. N Engl J Med, 2004, 351 (14): 1391-1402.
|
| 4 |
Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rates systematic review of the literature[J]. Clin Infect Dis, 2001, 32 (3): 358-366.
|
| 5 |
缪光胜，杨光钊.侵袭性肺曲霉病11例CT影像分析[J/CD].中华危重症医学杂志（电子版），2010，3(4):240-244.
|
| 6 |
Nucci M, Nouer SA, Grazziutti M, et al. Probable invasive aspergillosis without prespecified radiologic findings: proposal a for inclusion of new category of aspergillosis and implications for studying novel therapies[J]. Clin Infect Dis, 2010, 51 (11): 1273-1280.
|
| 7 |
De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group[J]. Clin Infect Dis, 2008, 46 (12): 1813-1821.
|
| 8 |
Leeflang MM, Debets-Ossenkopp YJ, Wang J, et al. Galactomannan detection for invasive aspergillosis in immunocompromised patients[J]. Cochrane Database Syst Rev, 2015 (12): CD007394.
|
| 9 |
Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis[J]. Clin Infect Dis, 2006, 42 (10): 1417-1427.
|
| 10 |
戴敏惠，潘频华.重症监护室侵袭性支气管肺曲霉病高危因素研究进展[J/CD].中华危重症医学杂志（电子版），2016，9(5):352-355.
|
| 11 |
Hammond SP, Marty FM, Bryar JM, et al. Invasive fungal disease in patients treated for newly diagnosed acte leukemia[J]. Am J Hematol, 2010, 85 (9): 695-699.
|
| 12 |
Maertens J, Verhaegen J, Lagrou K, et al. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation[J]. Blood, 2001, 97 (6): 1604-1610.
|
| 13 |
Logan PM, Primack SL, Miller RR, et al. Invasive aspergillosis of the airways: radiographic, CT, and pathologic findings[J]. Radiology, 1994, 193 (2): 383-388.
|
| 14 |
Franquet T, Muller NL, Gim'enez A, et al. Spectrum of pulmonary aspergillosis: histologic, clinical, and radiologic signs[J]. Radiographics, 2001, 21 (4): 825-837.
|
| 15 |
Marr KA, Balajee SA, McLaughlin L, et al. Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variable that affect performance[J]. J Infect Dis, 2004, 190 (3): 641-649.
|